20:22:39 EST Thu 19 Nov 2026
Enter Symbol
or Name
USA
CA



ASEP Medical Holdings Inc (2)
Symbol ASEP
Shares Issued 11,127,327
Close 2026-11-19 C$ 0.10
Market Cap C$ 1,112,733
Recent Sedar+ Documents

Asep Medical extends LIFE offering

2026-11-19 19:09 ET - News Release

Mr. Chris Dallin reports

ASEP MEDICAL ANNOUNCES EXTENSION OF LIFE OFFERING CLOSING DATE

Asep Medical Holdings Inc. has received approval from the Canadian Securities Exchange to extend the closing date of its previously announced non-brokered private placement financing under the listed issuer financing exemption (LIFE) to Jan. 3, 2027.

The extension has been granted to allow the company additional time to complete the LIFE offering. All other terms of the LIFE offering remain unchanged, as previously disclosed in the company's news release dated Oct. 9, 2026, and the related offering document.

The LIFE offering consists of up to nine million units of the company at a price of 10 cents per unit for maximum gross proceeds of $900,000. Each unit consists of one common share in the capital of the company and one common share purchase warrant. Each warrant entitles the holder to acquire one additional common share at an exercise price of 12 cents per common share for a period of 24 months following closing.

The LIFE offering is being completed pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106, Prospectus Exemptions.

The securities issued pursuant to the LIFE offering are expected to be immediately freely tradeable under applicable Canadian securities legislation.

The company intends to use the available funds from the LIFE offering, together with its existing additional sources of financing, primarily for the identification and evaluation of companies and technologies for potential acquisition and integration into the company's business, repayment of existing debts, and general working capital purposes.

The amended offering document related to the LIFE offering can be accessed under the company's profile on SEDAR+ and on the company's website. Prospective investors should read the offering document before making an investment decision.

Completion of the LIFE offering remains subject to the final approval of the CSE.

About Asep Medical Holdings Inc.

Asep Medical is an investment issuer focused on investing into biotechnology research and development assets and is based in Victoria, B.C., Canada. The company possesses a valuable portfolio of global patents for innovative diagnostic and therapeutic medical technologies. These technologies were developed over the past decade at the University of British Columbia under the guidance of Dr. Robert E.W. Hancock, one of the world's foremost microbiologists. Asep holds a significant interest in two private companies -- Sepset Biosciences (Asep's leading product, a sepsis diagnostic technology) and ABT Innovations (specializing in anti-biofilm technology). As the company's patented innovations address unmet medical needs, it presents a unique investment opportunity for both retail and institutional investors.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.